ATX-MS-1467
Apitope reclaims multiple sclerosis treatment from Merck after 7 years
October 17, 2016Sales and Marketing ATX-MS-1467, Apitope, Merck, multiple sclerosis
Apitope has announced it has reclaimed the global rights to its multiple sclerosis (MS) treatment ATX-MS-1467 from Merck for the …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
